A case of pseudomembranous colitis after voriconazole therapy

Yonsei Medical Journal

Volumn 52, Issue 5, 2011, Pages 863-865

  Kwon, Jae Cheol ^a   Kang, Min Kyu ^a   Kim, Si Hyun ^a   Choi, Su Mi ^a   Kim, Hee Je ^a   Min, Woo Sung ^a   Lee, Dong Gun ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Clostridium difficile; Diarrhea; Pseudomembranous colitis; Voriconazole

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; CASPOFUNGIN; CILASTATIN PLUS IMIPENEM; CYTARABINE; ESCITALOPRAM; ETOPOSIDE; ITRACONAZOLE; METRONIDAZOLE; MITOXANTRONE; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EMERGENCY CARE; HUMAN; HUMAN TISSUE; LOOSE FECES; LUNG ASPERGILLOSIS; MAJOR DEPRESSION; MALE; NEUTROPENIA; PSEUDOMEMBRANOUS COLITIS; SIGMOIDOSCOPY; TREATMENT DURATION;

ADULT; ANTIFUNGAL AGENTS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; LEUKEMIA, MYELOID, ACUTE; MALE; OPPORTUNISTIC INFECTIONS; PYRIMIDINES; TRIAZOLES;

EID: 79960987077     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2011.52.5.863     Document Type: Article

References (12)

1. Coté GA, Buchman AL. Antibiotic-associated diarrhoea. Expert Opin Drug Saf 2006;5:361-72.
2. Nguyen AJ, Nelson DB, Thurn JR. Pseudomembranous colitis after itraconazole therapy. Am J Gastroenterol 1999;94:1971-3.
3. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
4. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000;356:1255-9.
5. Bergogne-Bérézin E. Treatment and prevention of antibiotic associated diarrhea. Int J Antimicrob Agents 2000;16:521-6.
6. Kelly CP, LaMont JT. Clostridium difficile infection. Annu Rev Med 1998;49:375-90.
7. Miller M, Gravel D, Mulvey M, Taylor G, Boyd D, Simor A, et al. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis 2010;50:194-201.
8. Högenauer C, Hammer HF, Krejs GJ, Reisinger EC. Mechanisms and management of antibiotic-associated diarrhea. Clin Infect Dis 1998;27:702-10.
9. Johnson LB, Kauffman CA. Voriconazole: a new triazole antifungal agent. Clin Infect Dis 2003;36:630-7.
10. Drug information. Available from: URL:http://www.pfizer.com/files/products/uspi_vfend.pdf
11. Cohen R, Roth FJ, Delgado E, Ahearn DG, Kalser MH. Fungal flora of the normal human small and large intestine. N Engl J Med 1969;280:638-41.
12. Heard SR, Wren B, Barnett MJ, Thomas JM, Tabaqchali S. Clostridium difficile infection in patients with haematological malignant disease. Risk factors, faecal toxins and pathogenic strains. Epidemiol Infect 1988;100:63-72.